mirrorball: Development of a homogenous RSV neutralization assay on the mirrorball fluorescence cytometer

Human respiratory syncytial virus (RSV) is a syncytial virus that can cause serious respiratory tract infections, especially in infants and young children[1]. To date there is no licensed vaccine against RSV infection and the only preventative treatment option is the neutralizing anitbody palivizumab, which is given to high risk infants by passive administration[2]. Therefore there is a strong drive to identify novel RSV-neutralizing antibodies for therapeutic/preventative applications.

Here we present the development and implementation of a simple RSV-neutralization assay on TTP Labtech’s mirrorball fluorescence cytometer.

Download: mirrorball_homogenous-RSV-neutralization-assay_US-TTPLabtech-poster-2016